Logo 200 Logo 200 (Methylphenidate hydrochloride extended-release 20 mg)

Pill imprint Logo 200 Logo 200 has been identified as Methylphenidate hydrochloride extended-release 20 mg.

Methylphenidate is used in the treatment of adhd; narcolepsy; obesity; depression; fatigue (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 20 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.

See also related documents.

Imprint Search

Images for Logo 200 Logo 200

Methylphenidate hydrochloride extended-release 20 mg Logo 200 Logo 200
Methylphenidate hydrochloride extended-release
Imprint:
Logo 200
Logo 200
Strength:
20 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Actavis South Atlantic LLC
National Drug Code (NDC):
67767-0200
Inactive Ingredients:
sucrose
corn starch
hypromelloses
cellulose acetate
hypromellose acetate succinate 12070923 (3 mm2/s)
acetyltributyl citrate
acetone
magnesium silicate
water
titanium dioxide
gelatin
ferrosoferric oxide
shellac
potassium hydroxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)